Company Filing History:
Years Active: 2009-2010
Title: Innovations in Sepsis Detection by Zhouxin Shen
Introduction
Zhouxin Shen is an accomplished inventor based in San Diego, CA. He has made significant contributions to the field of mass spectrometry, particularly in the detection and prediction of sepsis. With a total of 2 patents, his work is paving the way for advancements in medical diagnostics.
Latest Patents
Zhouxin Shen's latest patents focus on innovative mass spectrometry techniques for determining the status of sepsis in individuals. One of his patents describes a method where a biomarker profile is resolved from a biological sample taken from the individual. This profile is then compared to a reference biomarker profile. The comparison classifies the individual as belonging to or not belonging to a reference population. The biomarker profiles consist of a plurality of ions, each having a mass-to-charge ratio of about 100 Daltons to about 1000 Daltons. These ions can be detected using electrospray ionization mass spectrometry in positive mode. The decision rule employed in this comparison, such as a classification tree, allows for the determination of sepsis status without requiring knowledge of the identity of the biomarkers involved.
Another patent by Shen involves a method of predicting the onset of sepsis in SIRS-positive individuals using similar mass spectrometry techniques. This method also relies on comparing biomarker profiles to classify individuals accurately.
Career Highlights
Zhouxin Shen is currently employed at Becton Dickinson and Company Limited, where he continues to innovate in the field of medical diagnostics. His work is instrumental in enhancing the accuracy and efficiency of sepsis detection methods.
Collaborations
Throughout his career, Zhouxin Shen has collaborated with notable colleagues, including Richard Ivey and Thomas M Gentle, Jr. These collaborations have contributed to the advancement of his research and the development of his patents.
Conclusion
Zhouxin Shen's contributions to mass spectrometry and sepsis detection represent a significant advancement in medical technology. His innovative approaches are set to improve patient outcomes and enhance diagnostic capabilities in healthcare.